Precision Cancer Care: Celecoxib’s Breakthrough!

Precision Cancer Care: Celecoxib’s Breakthrough! At the GI Cancer Symposium (Jan 25, 2025) at Dana-Faber Brigham, researchers used circulating tumor DNA to guide treatment for stage 3 colorectal cancer—and the results were revolutionary: • Celecoxib, originally for pain and inflammation, improved disease-free survival. • Excitingly, other studies show celecoxib can target PI3K—a key pathway upregulated in colorectal cancer, osteosarcomas, head & neck, and lung cancer. This is the power of precision cancer care—delivering the right treatment at the right time. For more on repurposed medications and advanced cancer care: 🔗 Visit Off-ScriptRX.com for consultations and detailed blogs. 💊 Visit my linktree (link in bio) to download a FREE Ivermectin crash course. 🎙️ Dive into our latest Prescribed Podcast episodes on YouTube and Spotify and explore more at Pre-Scribed.com (link in bio). Supporting evidence: https://www.dana-farber.org/newsroom/... #PrecisionCancerCare #CelecoxibBreakthrough #CancerInnovation #ColorectalCancer #GICancerSymposium #CirculatingTumorDNA #PI3KPathway #IntegrativeOncology #AdvancedCancerCare #MedicalInnovation #CancerResearch #OffScriptRX #PreScribedPodcast #PatientEmpowerment